Last reviewed · How we verify

NCT03314376

Prehabilitation in Patients on a Waiting List for a Transplant

Withdrawn NA Last updated 4 June 2024
What this trial tests

NA trial testing Prehabilitation program in Transplant Dysfunction. Withdrawn.

Timeline
2 January 2020
Primary endpoint
2 January 2024
1 December 2024

Quick facts

Lead sponsorUniversity of Malaga
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Start date2 January 2020
Primary completion2 January 2024
Estimated completion1 December 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Malaga

Who can join

Adults 50 to 90, any sex, with Transplant Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to prove the effects of a individualized prehabilitation program (muscular strength and endurance) in patients in a waiting list for a transplant. The investigators want to see if patients that did a prehabilitation program have better results in the postoperative period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Prehabilitation program

Trials testing the same drug.

Other recruiting trials for Transplant Dysfunction

Currently open trials in the same condition.

Other University of Malaga trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03314376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing